Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cheng

Showing results (571-580 of 828) with videos related to

Pageof 83
Sort By:
Postgraduate Medicine|February 10, 2022
Patients with ankylosing spondylitis have high risk of irritable bowel syndrome: a long-term nationwide population-based cohort studyHao-Yuan Feng, Chi-Ho Chan, Yu-Cheng Chu, et al.
Seminars in Arthritis and Rheumatism|February 5, 2025
Mortality and medical utilization in rheumatoid arthritis associated interstitial lung disease: A real-world, large-scale retrospective study comparing Janus kinase inhibitors and tumor necrosis factor inhibitorsPo-Cheng Shih, Qing-Hua Zou, Chih-Cheng Lai, et al.
Journal of the American Academy of Dermatology|December 30, 2024
Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysisTai-Li Chen, Jing-Yang Huang, Hui-Yun Lin, et al.
BMC Medicine|January 3, 2024
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetesFu-Shun Yen, Ming-Chih Hou, James Cheng-Chung Wei, et al.
International Journal of Rheumatic Diseases|November 28, 2023
Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo-controlled double-blinded clinical trialPui-Ying Leong, Huang-Hsi Chen, Shuo-Yan Gau, et al.
Frontiers in Pharmacology|November 29, 2023
Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroidSu-Boon Yong, Shuo-Yan Gau, Chia-Jung Li, et al.
Osteoarthritis and Cartilage|June 22, 2025
Methodological gaps in air pollution and osteoarthritis risk researchPeng-Yan Qiao, Yan-Li Yang, Jun-Kang Zhao, et al.
American Journal of Ophthalmology|June 22, 2025
Comment on: The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic NeuropathyAlan Y Hsu, Chun-Ju Lin, Yi-Ching Shao, et al.
Plos One|August 31, 2019
Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based studyKuo-An Chu, Chun-Hsiang Hsu, Mei-Chen Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes MellitusFu-Shun Yen, Hsiang-Chi Wang, Chun-Wei Pan, et al.
Pageof 83

Showing results (571-580 of 828) with videos related to

Sort By:
Pageof 83
Postgraduate Medicine|February 10, 2022
Patients with ankylosing spondylitis have high risk of irritable bowel syndrome: a long-term nationwide population-based cohort studyHao-Yuan Feng, Chi-Ho Chan, Yu-Cheng Chu, et al.
Seminars in Arthritis and Rheumatism|February 5, 2025
Mortality and medical utilization in rheumatoid arthritis associated interstitial lung disease: A real-world, large-scale retrospective study comparing Janus kinase inhibitors and tumor necrosis factor inhibitorsPo-Cheng Shih, Qing-Hua Zou, Chih-Cheng Lai, et al.
Journal of the American Academy of Dermatology|December 30, 2024
Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysisTai-Li Chen, Jing-Yang Huang, Hui-Yun Lin, et al.
BMC Medicine|January 3, 2024
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetesFu-Shun Yen, Ming-Chih Hou, James Cheng-Chung Wei, et al.
International Journal of Rheumatic Diseases|November 28, 2023
Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo-controlled double-blinded clinical trialPui-Ying Leong, Huang-Hsi Chen, Shuo-Yan Gau, et al.
Frontiers in Pharmacology|November 29, 2023
Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroidSu-Boon Yong, Shuo-Yan Gau, Chia-Jung Li, et al.
Osteoarthritis and Cartilage|June 22, 2025
Methodological gaps in air pollution and osteoarthritis risk researchPeng-Yan Qiao, Yan-Li Yang, Jun-Kang Zhao, et al.
American Journal of Ophthalmology|June 22, 2025
Comment on: The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic NeuropathyAlan Y Hsu, Chun-Ju Lin, Yi-Ching Shao, et al.
Plos One|August 31, 2019
Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based studyKuo-An Chu, Chun-Hsiang Hsu, Mei-Chen Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes MellitusFu-Shun Yen, Hsiang-Chi Wang, Chun-Wei Pan, et al.
Pageof 83